LYKA LABS LTD. - 500259 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 19, 2022 for Kunal Narendra Gandhi LYKA LABS LTD. - 500259 - Board Meeting Intimation for Board Meeting For Consideration Of Audited Financial Results For Fourth Quarter And Year Ended 31St March, 2022
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2022 ,inter alia, to consider and approve We wish to inform you that the meeting of Board of Directors of Lyka Labs Limited is scheduled to be held on Friday, 20th May, 2022 at Corporate Office at Mumbai. 1. To consider and adopt Standalone and Consolidated Audited Financial Results for the Fourth Quarter and Financial Year ended on 31st March, 2022. 2. To consider and adopt Standalone and Consolidated Audited Balance Sheet as of 31st March, 2022 along with Profit and Loss Account for the year ended on 31st March 2022. Kindly take the same on your record. LYKA LABS LTD. - 500259 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayLYKA LABS LTD. 2CINL24230GJ1976PLC008738 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 128.79 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Piyush G Hindia Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Yogesh B Shah Designation: CFO EmailId: [email protected] Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. LYKA LABS LTD. - 500259 - Revised Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015
In compliance with Regulation 40(9) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we enclose herewith a copy of Compliance Certificate dated 12th April, 2022 issued by Kaushal Doshi & Associates, practicing Company Secretaries for the financial year ended 31st March, 2022. LYKA LABS LTD. - 500259 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements), 2015 For The Half Year Ended 31St March, 2022
Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Compliance Certificate, duly signed by Authorized Signatory of M/s. Link Intime India Pvt Ltd, Share Transfer Agent of the Company and by the Company Secretary and Compliance Officer of the Company for the half year ended 31st March, 2022. LYKA LABS LTD. - 500259 - Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015
In compliance with Regulation 40(9) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we enclose herewith a copy of Compliance Certificate dated 12th April, 2022 issued by Kaushal Doshi & Associates, practicing Company Secretaries for the half year ended 31 March, 2022. LYKA LABS LTD. - 500259 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 31 March, 2022 received form M/s Link Intime India Pvt. Ltd., Registrar and Share Transfer Agent of the Company. LYKA LABS LTD. - 500259 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Piyush G HindiaDesignation :- Company Secretary and Compliance Officer LYKA LABS LTD. - 500259 - Clarification On Price Movement
We refer to your mail dated 11th April, 2022, seeking clarification on the price movement of our shares. In the matter, we wish to inform you that the price movement of our shares is regulated by the market forces and we do not have any concern with the said price movement. Further, we have been informing to the exchanges about the material information as required under Regulation 30 of SEBI LODR, 2015 whenever it take place. The present price movement is solely due to the market forces. LYKA LABS LTD. - 500259 - Updates on Open Offer
Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement to the Shareholders of Lyka Labs Ltd ("Target Company").